UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: UCB) | Delayed: 36.75 -0.37 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.12 | 52 Week High | $ | |||
| Open | $37.24 | 52 Week Low | $ | |||
| Day High | $37.24 | P/E | N/A | |||
| Day Low | $36.46 | EPS | $ | |||
| Volume | 722,850 | |||||
